Deborah Donnell, Ph.D.

Deborah Donnell Ph.D.
FACULTY MEMBER

Deborah Donnell, Ph.D.

Member
Vaccine and Infectious Disease Division, Fred Hutch

Member
Public Health Sciences Division, Fred Hutch

Fax: 206.667.4378
Mailstop: M2-C200

Dr. Deborah Donnell is a biostatistician with 25 years of experience in the design and analysis of clinical trials for HIV prevention. Her statistical leadership shapes pivotal trials in many areas of HIV prevention research and has included interventions to stop mother-to-child transmission; the treatment of opiate addiction; treatment as prevention in HIV-infected persons; and the use of pre-exposure prophylaxis, or PrEP — a once-a-day antiretroviral pill to prevent infection in those who are at high risk. She is the lead statistician for similar trials in the University of Washington Department of Global Heath, including numerous projects testing the most effective ways to expand use of PrEP in public health settings.

Other Appointments & Affiliations

Adjunct Professor, Department of Global Health
University of Washington

Education

University of Washington, 1987, Ph.D. (Statistics)

University of Auckland, 1982, M.A. (Mathematics)

University of Auckland, 1980, B.A. (Mathematics and Music)

Current Projects

Principal Investigator of the Statistical and Data Management Center of the HIV Prevention Trials Network

Phase 2b trial of VRC01 as antibody meditated prevention of HIV in women in sub-Saharan Africa and men who have se with men in the Americas.

Phase 3 randomized double-dummy double-blind trial of Injectable Cabotegravir compared to FTC/TDF for the Prevention of HIV infection in Men who have sex with men and Transgender women.

ECHO, Multi-Center, Open-Label, Randomized Clinical Trial of the Effect of Progestin-Only Contraception versus the Copper Intrauterine Device (IUD) on the Risk of HIV Acquisition in Young Women

Design and delivery of combination HIV prevention in young South African women

Delivery of integrated PrEP and ART for HIV prevention for couples in Kenya

Impact of Concurrent Initiation of DMPA Contraception and Tenofovir PrEP on Bone Loss in Young Women

HIV self-testing and PrEP to increase testing and prevention uptake among male partners and improve postpartum ART use in PMTCT B+ programs in Uganda

Scalable, Effective Delivery of Microbicides and PrEP for Young Women in Kenya and South Africa

PrEP for young South African women: Evaluating uptake by risk screening or a decision support tool and scaled adherence support using a SMART design

HIV Self-Testing to Improve the Efficiency of PrEP Delivery

Broadly Neutralizing Antibody Study: Phase 1

Find a Clinical Trial

Dr. Donnell in the News

Study shows ART lowers HIV transmission

Hutch News - June 01, 2010

The challenge of nevirapine resistance

Hutch News - February 02, 2006

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210.